Plus Therapeutics (PSTV) Short Interest Ratio & Short Volume → Like Tiny Crypto Retirement Funds (From Crypto 101 Media) (Ad) Free PSTV Stock Alerts $1.72 -0.01 (-0.58%) (As of 03/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Plus Therapeutics Short Interest DataCurrent Short Volume40,800 sharesPrevious Short Volume46,400 sharesChange Vs. Previous Month-12.07%Dollar Volume Sold Short$79,152.00Short Interest Ratio / Days to Cover1.1Last Record DateFebruary 29, 2024Outstanding Shares4,280,000 sharesFloat Size4,220,000 sharesShort Percent of Float0.97%Today's Trading Volume23,447 sharesAverage Trading Volume33,388 sharesToday's Volume Vs. Average70% Short Selling Plus Therapeutics ? Sign up to receive the latest short interest report for Plus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPSTV Short Interest Over TimePSTV Days to Cover Over TimePSTV Percentage of Float Shorted Over Time Ad Paradigm Press8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: Click to get the name of the cryptocurrency Plus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/202440,800 shares $79,152.00 -12.1%1.0%1.1 $1.94 2/15/202446,400 shares $92,336.00 +7.2%1.0%1.2 $1.99 1/31/202443,300 shares $87,033.00 -25.3%1.0%0.6 $2.01 1/15/202458,000 shares $120,060.00 +21.9%1.3%0.2 $2.07 12/31/202347,600 shares $83,304.76 -26.3%1.1%0.2 $1.75 12/15/202364,600 shares $123,386.00 -25.5%1.5%0.2 $1.91 Get the Latest News and Ratings for PSTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/202386,700 shares $147,390.00 -59.7%2.0%0.1 $1.70 11/15/2023215,000 shares $406,350.00 +441.6%4.9%0.3 $1.89 10/31/202339,700 shares $48,434.00 -43.8%0.9%0.1 $1.22 10/15/202370,600 shares $97,428.00 -27.6%2.5%0.2 $1.38 9/30/202397,500 shares $130,650.00 -30.6%3.4%0.2 $1.34 9/15/2023140,500 shares $195,295.00 +347.5%5.0%0.3 $1.39 8/31/202331,400 shares $87,606.00 -50.4%1.1%0.1 $2.79 8/15/202363,300 shares $153,819.00 +76.8%2.2%1.5 $2.43 7/31/202335,800 shares $88,068.00 +35.6%1.4%1 $2.46 7/15/202326,400 shares $54,648.00 -13.2%1.1%0.8 $2.07 6/30/202330,400 shares $61,408.00 -24.6%1.2%1 $2.02 6/15/202340,300 shares $122,512.00 -3.8%1.6%1.5 $3.04 5/31/202341,900 shares $168,438.00 -14.3%1.7%1.7 $4.02 5/15/202348,900 shares $213,693.00 +154.7%2.0%1.9 $4.37 4/30/202319,200 shares $74,822.40 -66.6%0.8%0.8 $3.90 4/15/202357,500 shares $15,939.00 -76.7%N/A0.2 $0.28 3/31/2023247,100 shares $71,659.00 -13.8%N/A0.9 $0.29 3/15/2023286,600 shares $80,391.30 +4.1%N/A0.9 $0.28 2/28/2023275,400 shares $93,691.08 -31.4%N/A0.8 $0.34 2/15/2023401,600 shares $156,624.00 -14.9%N/A1.2 $0.39 1/31/2023472,000 shares $204,517.60 +17.2%N/A1.4 $0.43 1/15/2023402,600 shares $192,523.32 +39.7%N/A1.2 $0.48 12/30/2022288,200 shares $91,359.40 -31.9%N/A0.7 $0.32 12/15/2022423,100 shares $132,007.20 -5.0%N/A0.6 $0.31 11/30/2022445,200 shares $179,282.04 -17.8%N/A0.5 $0.40 11/15/2022541,500 shares $234,956.85 -11.4%N/A0.4 $0.43 10/31/2022610,900 shares $287,123.00 -50.3%N/A0.1 $0.47 10/15/20221,230,000 shares $642,060.00 +388.9%N/A0.3 $0.52 9/30/2022251,600 shares $111,962.00 +74.0%N/A0.1 $0.45 9/15/2022144,600 shares $89,565.24 -73.5%N/A0 $0.62 8/31/2022545,600 shares $457,976.64 +865.7%N/A0.1 $0.84 8/15/202256,500 shares $32,041.15 +289.7%N/A0 $0.57 7/31/202214,500 shares $7,176.05 -67.5%N/A0.2 $0.49 7/15/202244,600 shares $22,643.42 +117.6%0.4%0.4 $0.51Central Bank Gold Heist In Progress (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. PSTV Short Interest - Frequently Asked Questions What is Plus Therapeutics' current short interest? Short interest is the volume of Plus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 29th, investors have sold 40,800 shares of PSTV short. 0.97% of Plus Therapeutics' shares are currently sold short. Learn More on Plus Therapeutics' current short interest. What is a good short interest ratio for Plus Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PSTV shares currently have a short interest ratio of 1.0. Learn More on Plus Therapeutics's short interest ratio. What is a good short interest percentage for Plus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.97% of Plus Therapeutics' floating shares are currently sold short. Is Plus Therapeutics' short interest increasing or decreasing? Plus Therapeutics saw a decrease in short interest in February. As of February 29th, there was short interest totaling 40,800 shares, a decrease of 12.1% from the previous total of 46,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Plus Therapeutics' float size? Plus Therapeutics currently has issued a total of 4,280,000 shares. Some of Plus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Plus Therapeutics currently has a public float of 4,220,000 shares. How does Plus Therapeutics' short interest compare to its competitors? 0.97% of Plus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Plus Therapeutics: NeuroMetrix, Inc. (3.07%), Vapotherm, Inc. (9.92%), GlucoTrack, Inc. (0.13%), Vivos Therapeutics, Inc. (2.09%), PolyPid Ltd. (0.33%), Minerva Surgical, Inc. (92.12%), ProSomnus, Inc. (2.59%), Intelligent Bio Solutions Inc. (2.05%), Acutus Medical, Inc. (7.87%), Sharps Technology, Inc. (0.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Plus Therapeutics stock? Short selling PSTV is an investing strategy that aims to generate trading profit from Plus Therapeutics as its price is falling. PSTV shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Plus Therapeutics? A short squeeze for Plus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PSTV, which in turn drives the price of the stock up even further. How often is Plus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PSTV, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: NeuroMetrix Short Squeeze Vapotherm Short Squeeze GlucoTrack Short Squeeze Vivos Therapeutics Short Squeeze PolyPid Short Squeeze Minerva Surgical Short Squeeze ProSomnus Short Squeeze Intelligent Bio Solutions Short Squeeze Acutus Medical Short Squeeze Sharps Technology Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PSTV) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceDid you make $29,000 two days with AI options trades?Prosper Trading AcademyThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing